GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AFT Pharmaceuticals AFT.NZ · NZD

Health Care · NZX · 🇳🇿 New Zealand

Compare

4.50

-2.17%

Close of 9 Nov 2026, in NZD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

AFT Pharmaceuticals — daily NZX:AFT

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View AFT Pharmaceuticals on TradingView ↗
Market value
NZD 471.9m
Last close × shares
Volume
11.7k
Shares, 9 Nov 2026
Price to earnings
34.5
Dividend yield
0.54%

About AFT Pharmaceuticals

Its shares trade on NZX under the ticker AFT.NZ. It has been listed since 22 December 2015. In the fiscal year to 31 March 2026, it reported revenue of NZD 256.6m and net income of NZD 14.8m. At that date it held total assets of NZD 218.6m and shareholders' equity of NZD 111.1m.

AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. The firm's segments include New Zealand, Australia, Asia and Rest of World. The firm's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others. The firm's NasoSURF Nebuliser is in pilot scale production. The firm is focused on conducting clinical for Maxigesic oral dose forms. The firm is also conducting clinical trials of Maxigesic intravenous (IV). Maxigesic PE is a cold and flu variant. Its subsidiary, AFT Pharmaceuticals (AU) Pty Ltd, is engaged in distribution of pharmaceuticals in Australia. Its subsidiary, AFT Pharmaceuticals Singapore Pte Ltd, is engaged in the registration of pharmaceuticals in Singapore. Its subsidiary, AFT Pharmaceuticals (S.E. Asia) Sdn Bhd, is engaged in the distribution of pharmaceuticals in Malaysia.

Figures and description from our data supplier, not checked against the company's own report.

More about AFT Pharmaceuticals →

Latest on AFT Pharmaceuticals

Our reporting

We have not reported on AFT Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is AFT Pharmaceuticals's ticker?

AFT Pharmaceuticals trades as AFT.NZ on NZX, under ISIN NZAFTE0001S4.

What was AFT Pharmaceuticals's last closing price?

4.50 on 9 Nov 2026. The figure is in NZD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.